Hermetica Superfood Encyclopedia
The Short Answer
Rubia cordifolia is an Ayurvedic herb containing anthraquinones and rubimaillin that demonstrates anti-inflammatory and neuroprotective properties. Its primary mechanism involves modulating cytokine production and enhancing antioxidant enzyme activity.
CategoryHerbs (Global Traditional)
GroupAyurveda
Evidence LevelModerate
Primary KeywordRubia cordifolia benefits
Synergy Pairings5
Rubia cordifolia — botanical close-up
Health Benefits
Origin & History
Natural habitat
Rubia cordifolia is a perennial climbing vine from the Rubiaceae family whose rhizome (underground stem) serves as the primary medicinal component in traditional Asian medicine systems. Medicinal preparations are typically derived from aqueous or methanol extracts of the roots and aerial parts, which contain quinone derivatives and other bioactive compounds.
“R. cordifolia has a long history in traditional Chinese medicine, where the rhizome is used for improving blood circulation, hemostasis (blood clotting control), and activation of collateral circulation. The plant is also used in broader Asian traditional medicine systems.”Traditional Medicine
Scientific Research
No human clinical trials, RCTs, or meta-analyses were identified for R. cordifolia. All available evidence comes from preclinical animal studies in rats and mice, with researchers explicitly noting that 'clinical safety data for R. cordifolia is lacking' and 'most studies are preclinical.'
Preparation & Dosage
Traditional preparation
Animal study dosages only: Aqueous extract 250-1,000 mg/kg body weight (oral), with 500 mg/kg showing efficacy in colitis models; Mollugin 10-40 mg/kg body weight; No standardized human dosing recommendations exist. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Rubia cordifolia (Indian Madder) is a medicinal root herb, not typically consumed as a food source, so conventional macronutrient profiling is limited. Key documented constituents include: ANTHRAQUINONES (primary bioactives) — Purpurin (0.1–0.3% dry weight), Munjistin, Pseudopurpurin, Xanthopurpurin, and Rubiadin are the dominant pigment compounds; NAPHTHOHYDROQUINONES — Mollugin is present at measurable concentrations in root extracts, active in studies at 20–40 mg/kg range (preclinical); TANNINS — Rubiprasin A, B, C and garancin-type tannins contribute astringent properties; TRITERPENOIDS — Oleanolic acid and related saponins present in root bark fractions; IRIDOIDS — Asperuloside and related glycosides detected in aerial parts; POLYPHENOLS — General phenolic content estimated at 15–25 mg GAE/g dry root extract in published assays; MINERALS (trace, from root material) — Iron, calcium, and potassium detected at low concentrations, not nutritionally significant at typical medicinal doses; FIBER — Root material contains structural cellulose/lignin but bioavailable dietary fiber is negligible in extract form; PROTEIN — Less than 5% by dry weight in crude root powder; BIOAVAILABILITY NOTE — Anthraquinone glycosides require gut microbiota hydrolysis for aglycone activation; phytosomal formulations (phosphatidylcholine complexes) have demonstrated enhanced absorption of lipophilic constituents like mollugin in preclinical models; standardized extracts are typically normalized to purpurin or anthraquinone content (1–5%).
How It Works
Mechanism of Action
Rubia cordifolia's anthraquinone compounds, particularly rubimaillin and purpurin, inhibit pro-inflammatory cytokine production including IL-1β and TNF-α. The herb upregulates endogenous antioxidant enzymes like superoxide dismutase (SOD) and catalase while reducing lipid peroxidation markers. These mechanisms contribute to its anti-inflammatory effects and potential neuroprotective activity.
Clinical Evidence
Current evidence for Rubia cordifolia is primarily preclinical, with animal studies showing reduced inflammatory markers in IBD models. Phytosomal formulations demonstrated increased SOD and catalase activity in rat sciatic nerve tissue studies. No human clinical trials have been published to date establishing therapeutic efficacy or optimal dosing. The existing research, while promising, requires human validation studies.
Safety & Interactions
Rubia cordifolia safety data in humans is limited due to lack of clinical trials. Traditional use suggests general tolerability, but potential side effects remain undocumented. The herb may theoretically interact with anticoagulant medications due to anthraquinone content. Pregnancy and lactation safety has not been established, so use should be avoided during these periods.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What are the main active compounds in Rubia cordifolia?
The primary bioactive compounds include anthraquinones such as rubimaillin, purpurin, and alizarin. These compounds are responsible for the herb's anti-inflammatory and antioxidant properties.
How much Rubia cordifolia should I take daily?
No standardized human dosage exists due to lack of clinical trials. Traditional Ayurvedic preparations typically use 1-3 grams of root powder daily, but optimal therapeutic dosing remains unestablished.
Can Rubia cordifolia help with inflammatory bowel disease?
Animal studies show promising results with reduced IL-1β and TNF-α levels in IBD models. However, no human trials have confirmed these effects, so efficacy in humans remains unproven.
Is Rubia cordifolia safe to take with blood thinners?
Potential interactions with anticoagulant medications are theoretically possible due to anthraquinone content. Consult a healthcare provider before combining with warfarin or other blood-thinning drugs.
What is the difference between regular and phytosomal Rubia cordifolia?
Phytosomal formulations use phospholipid complexing to enhance bioavailability and tissue penetration. Studies suggest phytosomal forms may provide superior antioxidant enzyme enhancement compared to standard extracts.
What does current clinical research show about Rubia cordifolia's effectiveness?
Most evidence for Rubia cordifolia comes from preclinical animal studies, which have demonstrated anti-inflammatory effects and neuroprotective potential in laboratory settings. However, high-quality human clinical trials remain limited, meaning effectiveness in people has not been robustly established compared to its traditional use in Ayurvedic medicine. Any health claims should be considered preliminary until larger, well-designed studies in humans are completed.
Who should avoid Rubia cordifolia supplements?
Pregnant and breastfeeding women should avoid Rubia cordifolia due to insufficient safety data in these populations. Individuals with kidney or liver disease should consult a healthcare provider before use, as the herb undergoes hepatic metabolism and renal elimination. Those with active bleeding disorders or scheduled surgery should also exercise caution given potential interactions with hemostasis.
What is the difference between standardized extracts and whole herb Rubia cordifolia?
Standardized extracts are manufactured to contain consistent levels of active compounds like anthraquinones and naphthoquinones, offering predictable potency across batches. Whole herb preparations contain the full spectrum of plant constituents but may have variable concentrations depending on growing conditions and harvesting methods. Standardized extracts provide better dosage control for clinical applications, while whole herb forms may offer synergistic benefits from multiple compounds working together.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w rubia-cordifolia curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
